Vaccine

16 stories about Vaccine
ד"ר טל זקס מנהל רפואי מודרנה

Moderna’s chief scientist says company initiated vaccine deal with Israel

16.11.20|Sophie Shulman
Israeli scientist Tal Zaks says Israel will be among the first to receive doses from the company’s European plant
חברת תרופות מודרנה חיסון קורונה מבוסטון מסוצ'סטס

Moderna joins Pfizer, says its vaccine is 94.5% effective in preventing Covid-19

16.11.20|Reuters
A key advantage of Moderna's vaccine is that it does not need ultra-cold storage like Pfizer's, making it easier to distribute
מטה חברת תרופות פייזר ניו יורק

Pfizer and BioNTech claim 90% effective rate for their Covid-19 vaccine

09.11.20|Reuters
The news comes at the same time that Israel is currently undergoing human trials of its own vaccine for deployment in 2021
הדמיה חיסון תרופה קורונה covid 19

Israel starts human trials of local Covid-19 vaccine aiming for a 2021 deployment

01.11.20|Reuters
Elementary students have also returned to school as a second nationwide lockdown comes to a gradual end
החיסון הישראלי לקורונה המכון הביולוגי

Israeli-made Covid-19 vaccine to be ready next summer

26.10.20|Adir Yanko, Ynet News
Head of Israel Institute of Biological Research says he is excited for what the future holds, adding “if there were five vaccines on the table, I’d choose the Israeli version”
המכון הביולוגי מעבדה חיסון קורונה

Israel's homegrown Covid-19 vaccine to enter human testing phase

26.10.20|Reuters
"Our final goal is 15 million rations for the residents of the State of Israel and for our close neighbours," said IIBR Director Shmuel Shapira.
דליה מגידו מנכ"לית נסוס פארמה

Nasal spray to stop spread of Covid-19? Israeli pharma company puts its product to the test

14.10.20|Yafit Ovadia
Israeli biopharmaceutical company in process of working on new mist treatment to combat spread of coronavirus in large populations
?Can technology prevent the next pandemic

Executives from the WHO, IBM and Johnson & Johnson weigh in: Can technology prevent the next pandemic?

01.10.20|Start-Up Nation Central, a CTech partner
Global, open-source collaboration among governments, public health bodies and researchers will likely provide the gateway to a forthcoming vaccine, and to better pandemic tracking, containment and treatment, experts say
Medicine doctor and robotics research and analysis

“Until a COVID-19 vaccine becomes available, modern tech can predict where epidemics will strike,” says Johnson & Johnson’s Chief Medical Officer of Global Public Health

03.09.20|Einat Paz-Frankel, Start-Up Nation Central, a CTech Partner
Dr. Alan Tennenberg will speak at Start-Up Nation Central's interactive online conference "The New Digital Age: The Role of Technological Innovation in the Post-COVID-19 World"
הדמיה חיסון תרופה קורונה covid 19

Elicio Therapeutics enters Covid-19 vaccine race, reports success in pre-clinical trials

19.08.20|Sophie Shulman
Boston company partially owned by Clal Biotechnology Industries plans to advance to clinical trials in Q4
חיסון תרופה קורונה אילוסטרציה

As the Covid-19 vaccine arms race intensifies, big money is at risk

10.08.20|Sophie Shulman
Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
הדמיה חיסון תרופה קורונה covid 19

Place your bets: Which company will reach a Covid-19 vaccine first?

02.08.20|Sophie Shulman
Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game
קורונה חולה מובלת לבית החולים החדש ב ווהאן סין 4.2.20

Israel signs deal to acquire Covid-19 vaccine from Moderna

16.06.20|Ynetnews and CTech
Moderna announced it was concluding its phase two testing for the vaccine and plans to begin phase three with 30,000 participants in July. The company claimed it could start production of the vaccine as soon as September of this year
בית חולים שדה לטיפול ב חולי קורונה ב איטליה

The War on Coronavirus Brings With it a Dangerous Fog

17.04.20|Dov Greenbaum
With nothing else to report on, mainstream media, social media, and fringe media are all inundating the public with so much conflicting information that they are all actively contributing to confusion and even false hopes regarding the pandemic
ביונדווקס BiondVax תמר בן ידידיה רון בבקוב

Flu Season Might Soon Pass, for Good

11.12.19|Lilach Baumer
The researchers behind Jerusalem-based BiondVax talked to Calcalist, discussing their potential universal flu vaccine, currently undergoing a phase 3 clinical trial
default image

Hepatitis B Vaccine Company VBI Vaccines Raises $72 Million

05.11.17|Meir Orbach
Investors included Israeli insurers, and healthcare company Opko Health